½ÃÀ庸°í¼­
»óǰÄÚµå
1547391

¼¼°èÀÇ ¹é½Å Àü´Þ ±â±â ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Vaccine Delivery Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹é½Å Àü´Þ ±â±â ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.06%·Î 2023³â 71¾ï 4, 147¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 143¾ï 4, 737¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¹é½Å Àü´Þ ±â±â´Â ¹é½ÅÀ» È¿°úÀûÀÌ°í ¾ÈÀüÇÏ°Ô °³Àο¡°Ô Åõ¿©ÇÏ´Â µ¥ »ç¿ëµÇ´Â µµ±¸ ¹× µµ±¸ÀÔ´Ï´Ù. ÀϹÝÀûÀÎ À¯ÇüÀº ÁÖ»ç±â, ÀÚµ¿ ºñȰ¼ºÈ­ ÁÖ»ç±â, Á¦Æ® ÁÖ»ç±â, ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ Àåºñ´Â Á¤È®ÇÑ º¹¿ë·®À» º¸ÀåÇϰí ÅëÁõÀ» ÃÖ¼ÒÈ­ÇÏ°í ¿À¿°°ú °¨¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ °í¾ÈµÇ¾ú½À´Ï´Ù. ¹é½Å Àü´ÞÀÇ Çõ½ÅÀº ƯÈ÷ ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼­ »ç¿ë, º¸°ü ¹× ¿î¼ÛÀ» ¿ëÀÌÇÏ°Ô ÇÔÀ¸·Î½á ¿¹¹æ Á¢Á¾·üÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. È¿°úÀûÀÎ ¹é½Å Àü´Þ ±â±â´Â °øÁß º¸°Ç¿¡ ¸Å¿ì Áß¿äÇÏ¸ç ±¤¹üÀ§ÇÑ ¿¹¹æ Á¢Á¾°ú °¨¿°À» ¿¹¹æÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¹é½Å Àü´Þ ±â±â ½ÃÀåÀº ¿¹¹æ Á¢Á¾ Ä·ÆäÀÎÀ» ÅëÇØ Àü¿°º´°ú ½Î¿ì°í Àü¿°º´À» ¿¹¹æÇÏ·Á´Â ¼¼°èÀÇ ³ë·ÂÀ¸·Î Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. COVID-19, ÀÎÇ÷翣ÀÚ, È«¿ª µîÀÇ Áúº´¿¡ ´ëÇÑ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁö´Â °¡¿îµ¥, ¹é½ÅÀÇ ¾ÈÀüÇϰí È¿À²ÀûÀÌ°í Æí¸®ÇÑ Åõ¿©¸¦ º¸ÀåÇÏ´Â Çõ½ÅÀûÀÎ ¹é½Å Àü´Þ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ Àåºñ´Â ÁÖ»ç±â, ÁÖ»ç ¹Ù´Ã, ÀÚµ¿ ÁÖ»ç±â, ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡¿Í °°Àº ´Ù¾çÇÑ ±â¼úÀ» Æ÷ÇÔÇÏ¸ç ¹é½ÅÀ» Á¤È®ÇÏ°Ô Àü´ÞÇÏ°í ¹Ù´Ã Â±â ¼Õ»ó°ú ¹é½Å ³¶ºñÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ¿¹¹æÁ¢Á¾È®´ë ÇÁ·Î±×·¥(EPI) µî ÀÌ´Ï¼ÅÆ¼ºê¿¡ µÞ¹ÞħµÈ ½ÅÈï ±¹°¡¿¡¼­ÀÇ ¹é½ÅÁ¢Á¾·ü È®´ë°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÅëÁõÀÌ ¾ø°í ¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê´Â Àü´Þ ½Ã½ºÅÛ °³¹ß°ú °°Àº ±â¼úÀû Áøº¸´Â ±× ¼ö¿ë°ú äÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ƯÈ÷ ¾Ï ¸é¿ª¿ä¹ýÀ̳ª DNA ¹é½Å µî, ¸ÂÃãÇü ÀǷᳪ Ç¥ÀûÀ» Á¼Èù ¹é½Å µô¸®¹ö¸®¿¡ ´ëÇÑ ÁÖ¸ñÀÇ °íÁ¶°¡, Ư¼öÇÑ Àü´Þ ÀåÄ¡¿¡ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ÀÎÇÁ¶ó¸¦ °­È­ÇÏ°í ¹é½Å À¯Åë ä³ÎÀ» °³¼±Çϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÆÄÆ®³Ê½ÊÀº ¹é½Å Àü´Þ ±â±â Á¦Á¶¾÷ü¿¡°Ô À¯¸®ÇÑ ½ÃÀå Á¶°ÇÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. ¼¼°è Àα¸°¡ Áõ°¡ÇÏ°í ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó °í±Þ ¹é½Å Àü´Þ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¿ø°ÝÁöÀÇ ³ôÀº ºñ¿ë°ú ¹°·ù °úÁ¦´Â ¾ÕÀ¸·Î ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Force ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØÀÇ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¹é½Å Àü´Þ ±â±â ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹é½Å Àü´Þ ±â±â »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±Ù¹ýÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

¹é½Å Àü´Þ ±â±â ½ÃÀå º¸°í¼­´Â ±¹°¡º° ¹× Áö¿ªº° ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇϰí Àü·« ´ã´çÀÚ°¡ °¢ Á¦Ç° ¹× ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ½Äº°Çϰí ÇâÈÄ ºñÁî´Ï½º ±âȸ¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ªº° ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ¹é½Å ¹è´Þ ÀåÄ¡ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì Google¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ÇöȲ

Á¦3Àå ¹é½Å Àü´Þ ±â±â - »ê¾÷ ºÐ¼®

  • ¼Ò°³ : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü À϶÷
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀ̾î À϶÷
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¹é½Å Àü´Þ ±â±â ½ÃÀå ºÐ¼® : µð¹ÙÀ̽ºº°

  • µð¹ÙÀ̽ºº° °³¿ä
  • µð¹ÙÀ̽ºº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ÁÖ»ç±â
  • Á¦Æ® ÀÎÁ§ÅÍ
  • ±âŸ

Á¦6Àå ¹é½Å Àü´Þ ±â±â ½ÃÀå ºÐ¼® : Åõ¿© °æ·Îº°

  • Åõ¿© °æ·Îº° °³¿ä
  • Åõ¿© °æ·Îº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • Çdz» Á¢Á¾
  • ±ÙÀ°³» ¹é½Å Á¢Á¾
  • ÇÇÇÏÁ¢Á¾
  • ±âŸ ¹é½ÅÁ¢Á¾

Á¦7Àå ¹é½Å Àü´Þ ±â±â ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° À϶÷
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ¹é½Å Àü´Þ ±â±â ±â¾÷°æÀï ±¸µµ

  • ¹é½Å Àü´Þ ±â±â ½ÃÀå °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇÕÀÇ
  • ÇÕº´ ¹× Àμö
  • ½ÅÁ¦Ç° °¡¹Ì½Ã
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Becton Dickinson & Company
  • Bioject Medical Technologies Inc.(Inovio Pharmaceutical Inc.)
  • PharmaJet
  • Vaxxas
  • Gerresheimer AG SCHOTT AG
  • Corium International Inc.
  • 3M
BJH 24.09.24

The global demand for Vaccine Delivery Devices Market is presumed to reach the market size of nearly USD 14347.37 Million by 2032 from USD 7141.47 Million in 2023 with a CAGR of 8.06% under the study period 2024-2032.

Vaccine delivery devices are tools and instruments used to administer vaccines effectively and safely to individuals. Common types include syringes, auto-disable syringes, jet injectors, and microneedle patches. These devices are designed to ensure precise dosage, minimize pain, and reduce the risk of contamination and infection. Innovations in vaccine delivery aim to improve immunization coverage, especially in resource-limited settings, by enhancing ease of use, storage, and transportation. Effective vaccine delivery devices are crucial for public health, enabling widespread immunization and the prevention of infectious diseases.

MARKET DYNAMICS

The vaccine delivery devices market is witnessing significant growth driven by global efforts to combat infectious diseases and prevent pandemics through vaccination campaigns. With the increasing focus on immunization programs against diseases such as COVID-19, influenza, and measles, there is a growing demand for innovative vaccine delivery devices that ensure safe, efficient, and convenient administration of vaccines. These devices encompass various technologies, including syringes, needles, auto-injectors, and microneedle patches, designed to deliver vaccines accurately and minimize the risk of needle stick injuries and vaccine wastage. Additionally, the expanding vaccination coverage in developing countries, supported by initiatives such as the World Health Organization's Expanded Program on Immunization (EPI), is driving market growth. Technological advancements, such as the development of pain-free and needle-free delivery systems, are further enhancing their acceptance and adoption. Moreover, the rising focus on personalized medicine and targeted vaccine delivery, particularly in cancer immunotherapy and DNA vaccines, drives the demand for specialized delivery devices. Furthermore, government initiatives and partnerships to strengthen healthcare infrastructure and improve vaccine distribution channels create favorable market conditions for vaccine delivery device manufacturers. As the global population grows and the need for vaccination programs intensifies, the demand for advanced vaccine delivery devices is expected to rise, driving market expansion. However, remote areas' high costs and logistical challenges may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Vaccine Delivery Devices. The growth and trends of Vaccine Delivery Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Vaccine Delivery Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device

  • Syringes
  • Jet Injectors
  • Other Devices

By Route of Administration

  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination
  • Other Vaccinations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Vaccine Delivery Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Vaccine Delivery Devices market include Becton Dickinson & Company, Bioject Medical Technologies Inc. (Inovio Pharmaceutical Inc.), PharmaJet, Vaxxas, Gerresheimer AG SCHOTT AG, Corium International Inc., 3M. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. VACCINE DELIVERY DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Device
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VACCINE DELIVERY DEVICES MARKET ANALYSIS BY DEVICE

  • 5.1. Overview By Device
  • 5.2. Historical and Forecast Data Analysis By Device
  • 5.3. Syringes Historic and Forecast Sales By Regions
  • 5.4. Jet Injectors Historic and Forecast Sales By Regions
  • 5.5. Other Devices Historic and Forecast Sales By Regions

6. GLOBAL VACCINE DELIVERY DEVICES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data Analysis By Route of Administration
  • 6.3. Intradermal Vaccination Historic and Forecast Sales By Regions
  • 6.4. Intramuscular Vaccination Historic and Forecast Sales By Regions
  • 6.5. Subcutaneous Vaccination Historic and Forecast Sales By Regions
  • 6.6. Other Vaccinations Historic and Forecast Sales By Regions

7. GLOBAL VACCINE DELIVERY DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE VACCINE DELIVERY DEVICES COMPANIES

  • 8.1. Vaccine Delivery Devices Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF VACCINE DELIVERY DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Becton Dickinson & Company
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Bioject Medical Technologies Inc. (Inovio Pharmaceutical Inc.)
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. PharmaJet
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Vaxxas
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Gerresheimer AG SCHOTT AG
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Corium International Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. 3M
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦